Clinical Research Site

Brandon, Florida 33511

2 studies enrolling now · 10 studies all time

What they study most

Agitation, Agitation in Patients With Dementia of the Alzheimer's Type, Agitation, Psychomotor, Alzheimer Disease, Cataplexy, Excessive Daytime Sleepiness, Excessive Sleepiness, Hidradenitis Suppurativa, Major Depressive Disorder, Narcolepsy, Shift-work Disorder

Studies at this site

• Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN) — Recruiting now
• A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms — Recruiting now
• An Open-Label Study to Assess the Long-term Safety of AXS-05 in Subjects With Dementia of the Alzheimer's Type, ADVANCE-2 and ACCORD-2 Extension Study — Stopped early
• A Study to Assess the Efficacy and Safety of AXS-12 (Reboxetine) in Patients With Narcolepsy — Completed
• Progressing TAAR-1, Dopamine, and Norepinephrine in Depression Using Solriamfetol — Completed
• A Study to Assess the Long-term Safety and Efficacy of AXS-05 in Subjects With Alzheimer's Disease Agitation — Completed
• A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation — Completed
• A Study to Assess the Long-term Efficacy and Safety of AXS-12 (Reboxetine) in Subjects With Narcolepsy (ENCORE) — Completed
• Hidradenitis Suppurativa Study of Izokibep — Stopped early
• Efficacy, Safety and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type — Completed